Review of nucleic acid amplification tests and clinical prediction rules for diagnosis of tuberculosis in acute care facilities.

about

Clinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of Mycobacterium Tuberculosis: A 10-Year Longitudinal Study.Use of Nucleic Acid Amplification Tests in Tuberculosis Patients in California, 2010-2013.

P2860

Q33609475-81D6AF93-6DFA-45F9-B3DE-8DCCA4553313 Q37487563-2B82EE4E-D426-4AFE-ABD0-168ABA04107B

P2860

Review of nucleic acid amplification tests and clinical prediction rules for diagnosis of tuberculosis in acute care facilities.

Item

http://www.wikidata.org/entity/Q38545695

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Review of nucleic acid amplifi ...... osis in acute care facilities.

@en

type

Item

label

Review of nucleic acid amplifi ...... osis in acute care facilities.

@en

prefLabel

Review of nucleic acid amplifi ...... osis in acute care facilities.

@en

P1476

Review of nucleic acid amplifi ...... losis in acute care facilities

@en

P2093

Amit S Chitnis

http://www.w3.org/2001/XMLSchema#string

Gisela F Schecter

http://www.w3.org/2001/XMLSchema#string

Jennifer M Flood

http://www.w3.org/2001/XMLSchema#string

Pennan M Barry

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in the diagnosis and treatment of tuberculosis.

Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis.

Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression

Factors associated with mortality in patients with tuberculosis

Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review.

Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.

Patients diagnosed with tuberculosis at death or who died during therapy: association with the human immunodeficiency virus

Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States.

Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California

Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. a hypothetical trial.

P304

1215-1225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/ICE.2015.145

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

J Lucian Davis

P577

2015-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26166303

http://www.w3.org/2001/XMLSchema#string

Review of nucleic acid amplification tests and clinical prediction rules for diagnosis of tuberculosis in acute care facilities.

about

P2860

P2860

Review of nucleic acid amplification tests and clinical prediction rules for diagnosis of tuberculosis in acute care facilities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698